(Q28368045)

English
No label defined

scientific article

Statements

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors (English)
0 references
0 references
0 references
A M Vandamme
0 references
M J Pérez-Pérez
0 references
H Zhang
0 references
L Vrang
0 references
B Oberg
0 references
K Bäckbro
0 references
T Unge
0 references
A San-Félix
0 references
1 August 1993
0 references
90
0 references
15
0 references
6952-6
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit